Inhaled Antibiotics: A Promising New Approach to Combating Lung Infections Unveiling
The use of breathe in antibiotics to treat lung infections dates back to the 1970s when amphotericin B was first administered through nebulizers to treat aspergillosis, a fungal infection of the lungs. However, it was not until the 1990s that significant research was conducted to refine the delivery methods and develop newer inhaled antibiotic formulations.
Get more insights on Inhaled Antibiotics
https://www.newswirestats....
The use of breathe in antibiotics to treat lung infections dates back to the 1970s when amphotericin B was first administered through nebulizers to treat aspergillosis, a fungal infection of the lungs. However, it was not until the 1990s that significant research was conducted to refine the delivery methods and develop newer inhaled antibiotic formulations.
Get more insights on Inhaled Antibiotics
https://www.newswirestats....
Inhaled Antibiotics Market Size
Global inhaled antibiotics market is estimated to be valued at US$ 1616.61 Bn in 2024 and is expected to exhibit a CAGR of 6.9%
https://www.newswirestats.com/the-inhaled-antibiotics-market-is-growing-on-trend/
3 months ago
